Weekly versus biweekly bortezomib given in patients with indolent non-Hodgkin lymphoma: A meta-analysis

Open Access

Peer-reviewed

Research Article

Ting Yuan,

Affiliation Department of Hematology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong, P.R. China
⨯
Feng Zhang,

Affiliation Department of Hematology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong, P.R. China
⨯
Qing-min Yao,

Affiliation Department of Hematology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong, P.R. China
⨯
Yan-xia Liu,

Affiliation Department of Hematology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong, P.R. China
⨯
Xiao-juan Zhu,

Affiliation Department of Hematology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong, P.R. China
⨯
Xin Wang

* E-mail: xinw007@126.com

Affiliation Department of Hematology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong, P.R. China
⨯

Reader Comments (0)

Lymphoma
Is the Subject Area "Lymphoma" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Database searching
Is the Subject Area "Database searching" applicable to this article?

Thanks for your feedback.
Diarrhea
Is the Subject Area "Diarrhea" applicable to this article?

Thanks for your feedback.
Nausea
Is the Subject Area "Nausea" applicable to this article?

Thanks for your feedback.
Neutropenia
Is the Subject Area "Neutropenia" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.